Schedule a meeting, or stop by our stand to discuss your complex biologic or bioconjugate program with our experts during CPHI Frankfurt 2025, 28-30 October.

We welcome the opportunity to schedule some time to connect on your project-specific needs and to provide you with an update on our expanded global discovery, development and manufacturing capabilities.

From antibodies (mAbs) to recombinant vaccines and bioconjugates- including ADCs, radioconjugates, and oligonucleotides, our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.